Vireo Growth has purchased a major cannabis cultivation campus in Florida from its landlord for $21 million, marking the multi-state operator's latest move to consolidate its vertical integration in one of the nation's largest medical cannabis markets.
The acquisition, completed through a Vireo subsidiary, gives the company full ownership of a cultivation facility that currently supplies its 108 dispensaries across Florida. The deal converts what was previously a landlord-tenant relationship into direct property ownership.
Florida's medical cannabis market has attracted significant capital investment since the state expanded its program in 2016. The state's population of more than 22 million residents and its vertical integration requirements—which mandate that licensed operators control cultivation, processing, and retail—have made real estate acquisitions a strategic priority for MSOs operating there.
Vertical Integration Economics
The $21 million purchase price reflects the premium value of licensed cultivation facilities in Florida, where the number of medical marijuana treatment center licenses remains limited. Operators in the state must grow and process all products they sell in their own dispensaries.
Vireo's decision to buy rather than lease comes as several MSOs have moved to own rather than rent their cultivation and processing facilities. The strategy reduces long-term operating costs and provides more control over supply chain operations.
The company operates dispensaries under the Vireo Health brand in Florida, where it competes with larger MSOs including Trulieve, Curaleaf, and Verano. Florida's medical cannabis program served approximately 900,000 active patients as of late 2024.
Florida's Evolving Market
The timing of Vireo's acquisition coincides with uncertainty around Florida's adult-use cannabis market. Amendment 3, which would have legalized recreational cannabis, failed to reach the 60% threshold needed for passage in November 2024, receiving roughly 56% voter support.
Despite that setback, Florida's medical program continues to generate substantial revenue. The state recorded more than $2 billion in medical cannabis sales in 2023, making it one of the top three medical markets nationally alongside California and Arizona.
Industry analysts note that real estate acquisitions provide MSOs with tangible assets that can appreciate over time, particularly in markets where license values remain high. The deals also offer potential tax advantages compared to lease payments, though operators must balance those benefits against the upfront capital requirements.
What's Next
Vireo has not disclosed whether it plans additional real estate acquisitions in Florida or other markets where it operates. The company also has operations in Minnesota, Maryland, and Arizona.
The Florida cannabis market faces continued political uncertainty. Governor Ron DeSantis actively campaigned against Amendment 3, and the legislature has shown little appetite for pursuing adult-use legalization through statutory means. That leaves Florida's medical program as the state's only legal cannabis market for the foreseeable future.
For Vireo and other MSOs with significant Florida operations, that means continued focus on maximizing efficiency and market share within the existing medical framework. Owning rather than leasing cultivation facilities is one way to improve margins in a competitive market where wholesale prices have declined and retail competition has intensified.
This article is based on original reporting by mjbizdaily.com.
